Genentech
Jun 17, 2008
Genentech Settles With MedImmune Over Cabilly Patent
On the one hand, you'll likely never find anything so aptly named in finance. It is indeed a beige book.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Two drugs don't boost lung cancer survival: Roche | Oct 8 | gdpawel | 1 |
| Cancer medication linked to liver damage deaths | Sep 24 | poconoweeze | 1 |
| FDA alerts doctors to fatal case of rare brain ... | Sep 16 | Steve_G | 9 |
| FDA cites brain virus with Genentech, Biogen drug | Sep 12 | anon | 2 |
| Study outcome won't sway company on eye drug | Sep '08 | Sandy | 1 |
| Study won't sway company to pursue cheaper eye ... | Aug '08 | Greed sucks | 3 |
| Drug maker says study won't change plans | Aug '08 | Larry | 1 |
Sagittarius
Most Popular